<DOC>
	<DOCNO>NCT00160589</DOCNO>
	<brief_summary>Two week study evaluate efficacy safety Levocetirizine Desloratadine patient suffer Allergic Rhinitis ( AR )</brief_summary>
	<brief_title>LEADER ( LEvocetirizine And DEsloratadine Allergic Rhinitis )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>At least 2year history Allergic Rhinitis become symptomatic annual grass pollen season . A skin test grass pollens positive : Have rhinitis symptom severity mean T4SS baseline period must 6 . Have associate asthma require corticosteroid treatment , Have atopic dermatitis urticaria require antihistamine treatment administration oral topical corticosteroid ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Allergic Rhinits , Symptoms ( sneeze , rhinorrhea , nasal/ocular pruritus , nasal congestion ) , LEADER , Xyzal , Levocetirizine</keyword>
</DOC>